| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 5.11e-05 | 8 | 197 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 5.11e-05 | 8 | 197 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 9.68e-05 | 2 | 197 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 9.68e-05 | 2 | 197 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 9.68e-05 | 2 | 197 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 9.68e-05 | 2 | 197 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.47e-04 | 11 | 197 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | small RNA 2'-O-methyltransferase activity | 2.89e-04 | 3 | 197 | 2 | GO:0090486 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.18e-04 | 14 | 197 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 3.18e-04 | 14 | 197 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.38e-04 | 34 | 197 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 3.94e-04 | 15 | 197 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 5.74e-04 | 4 | 197 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 5.74e-04 | 4 | 197 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 9.50e-04 | 5 | 197 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 9.50e-04 | 5 | 197 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 9.50e-04 | 5 | 197 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | IRGM PSG3 PSG4 MYO10 PSG9 DENND1C KCNJ2 PLA2G4A PLEKHF2 GRAMD2A | 1.22e-03 | 316 | 197 | 10 | GO:0035091 |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 1.45e-03 | 23 | 197 | 3 | GO:0010485 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.45e-03 | 23 | 197 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.64e-03 | 24 | 197 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | ubiquinone binding | 1.97e-03 | 7 | 197 | 2 | GO:0048039 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.08e-03 | 230 | 197 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.12e-03 | 55 | 197 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 2.32e-03 | 27 | 197 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 2.57e-03 | 58 | 197 | 4 | GO:0051018 | |
| GeneOntologyMolecularFunction | protein kinase activity | MYLK PDK4 MELK PIK3CG STK39 FGFR3 POMK STK24 ANKK1 RIPK3 MAP3K8 GSK3A MKNK1 ALPK2 | 2.60e-03 | 600 | 197 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | filamin binding | 2.86e-03 | 29 | 197 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 2.86e-03 | 29 | 197 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.91e-03 | 60 | 197 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | actin binding | MYLK PSG3 PSG4 MYO9A MYO10 PSG9 ANLN ABI3BP MYO1H MACF1 TNS1 PALLD | 2.95e-03 | 479 | 197 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | phospholipid binding | CPNE2 IRGM PSG3 PSG4 MYO10 PSG9 DENND1C KCNJ2 PLA2G4A PLCB2 UNC13B PLEKHF2 GRAMD2A | 3.19e-03 | 548 | 197 | 13 | GO:0005543 |
| GeneOntologyMolecularFunction | ATP-dependent activity | SETX MYO9A ATAD5 MYO10 DHX15 BPTF UBA1 KIF26B DDX60 MYO1H FANCM ATF7IP ERCC6L2 MACF1 | 3.20e-03 | 614 | 197 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA 2'-O-methyltransferase activity | 3.33e-03 | 9 | 197 | 2 | GO:0062105 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | MELK PIK3CG STK39 STK24 ANKK1 RIPK3 MAP3K8 GSK3A MKNK1 ALPK2 | 3.34e-03 | 363 | 197 | 10 | GO:0106310 |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 3.66e-03 | 149 | 197 | 6 | GO:1990782 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.25e-05 | 21 | 197 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 7.53e-05 | 46 | 197 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 7.53e-05 | 46 | 197 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 7.60e-05 | 74 | 197 | 6 | GO:0070918 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 MED14 CDAN1 BPTF UBN1 PER2 UBR5 BRPF1 MSL3 MKI67 BRD1 TDRD5 BEND3 MSL1 ZDBF2 TEX15 HUWE1 GSK3A BRF1 ATF7IP ERCC6L2 ZNF518B NFAT5 | 8.71e-05 | 999 | 197 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 8.72e-05 | 25 | 197 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.02e-04 | 49 | 197 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 1.03e-04 | 193 | 197 | 9 | GO:0071902 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.19e-04 | 27 | 197 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | IRGM PSG3 PSG4 PSG9 GHR PTPN1 PIK3CG SPATC1L RIPK3 WDR59 PRLR PROX1 | 1.45e-04 | 350 | 197 | 12 | GO:0045860 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | IRGM PSG3 PSG4 PSG9 GHR PTPN1 PIK3CG FGFR3 SPATC1L RIPK3 WDR59 PRLR PROX1 | 1.48e-04 | 405 | 197 | 13 | GO:0033674 |
| Domain | Centrosomal_protein_57kDa | 1.07e-04 | 2 | 194 | 2 | IPR010597 | |
| Domain | Cep57_MT-bd_dom | 1.07e-04 | 2 | 194 | 2 | IPR024957 | |
| Domain | Cep57_CLD | 1.07e-04 | 2 | 194 | 2 | IPR025913 | |
| Domain | Cep57_CLD | 1.07e-04 | 2 | 194 | 2 | PF14073 | |
| Domain | Cep57_MT_bd | 1.07e-04 | 2 | 194 | 2 | PF06657 | |
| Domain | - | IGFN1 MYLK PSG3 PSG4 PSG7 PSG9 GHR FGFR3 PAPPA2 ABI3BP MILR1 IFNLR1 CD2 ATF7IP NFAT5 PALLD PRLR ALPK2 | 1.98e-04 | 663 | 194 | 18 | 2.60.40.10 |
| Domain | Ribosomal_L1-like | 3.20e-04 | 3 | 194 | 2 | IPR023674 | |
| Domain | Ribosomal_L1_2-a/b-sand | 3.20e-04 | 3 | 194 | 2 | IPR016094 | |
| Domain | Ribosomal_L1_3-a/b-sand | 3.20e-04 | 3 | 194 | 2 | IPR016095 | |
| Domain | Ribosomal_L1 | 3.20e-04 | 3 | 194 | 2 | PF00687 | |
| Domain | Ribosomal_L1/biogenesis | 3.20e-04 | 3 | 194 | 2 | IPR028364 | |
| Domain | Ribosomal_L1 | 3.20e-04 | 3 | 194 | 2 | IPR002143 | |
| Domain | - | 3.20e-04 | 3 | 194 | 2 | 3.30.190.20 | |
| Domain | Ig-like_fold | IGFN1 MYLK PSG3 PSG4 PSG7 PSG9 GHR FGFR3 PAPPA2 ABI3BP MILR1 IFNLR1 CD2 ATF7IP NFAT5 PALLD PRLR ALPK2 | 4.21e-04 | 706 | 194 | 18 | IPR013783 |
| Domain | HEMATOPO_REC_L_F1 | 6.35e-04 | 4 | 194 | 2 | PS01352 | |
| Domain | Long_hematopoietin_rcpt_CS | 6.35e-04 | 4 | 194 | 2 | IPR003528 | |
| Domain | HEAT_REPEAT | 8.04e-04 | 70 | 194 | 5 | PS50077 | |
| Domain | IGc2 | 8.05e-04 | 235 | 194 | 9 | SM00408 | |
| Domain | Ig_sub2 | 8.05e-04 | 235 | 194 | 9 | IPR003598 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 4.64e-05 | 8 | 135 | 3 | M27135 | |
| Pathway | REACTOME_XENOBIOTICS | 6.18e-05 | 23 | 135 | 4 | M5372 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 6.92e-05 | 9 | 135 | 3 | M27143 | |
| Pathway | REACTOME_XENOBIOTICS | 8.70e-05 | 25 | 135 | 4 | MM14846 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.34e-04 | 11 | 135 | 3 | M27130 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 1.59e-04 | 29 | 135 | 4 | M2920 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 1.77e-04 | 12 | 135 | 3 | M48064 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX MYO9A DPP8 MELK PPM1H CEP170 ANLN SYDE2 ZBTB21 SEC16A ZNF286B BRD1 DOP1B DSC2 KIF26B WDR59 GSK3A FAM83B FRMD6 MACF1 SCRIB CRYBG3 PALLD | 1.08e-09 | 861 | 199 | 23 | 36931259 |
| Pubmed | MYO10 GON4L PER2 UBR5 SEC16A CLEC16A DOP1B UNC13B BEND3 HEATR5A PPP2R5E SPHKAP MACF1 SCRIB SPEN NFAT5 | 2.05e-09 | 407 | 199 | 16 | 12693553 | |
| Pubmed | MYO9A PTPN12 UBR5 SEC16A KIF26B ZDBF2 GSK3A MACF1 SCRIB CRYBG3 PALLD | 3.88e-08 | 209 | 199 | 11 | 36779422 | |
| Pubmed | SDE2 ATAD5 RSL1D1 MED14 GON4L NCBP1 CEP170 CDAN1 UBN1 ANLN MSL3 SEC16A BRD1 CCDC14 MSL1 HUWE1 SCRIB SPEN | 4.01e-08 | 645 | 199 | 18 | 25281560 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.21e-07 | 184 | 199 | 10 | 32908313 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 35134542 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 1.85e-07 | 3 | 199 | 3 | 21977947 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 23118231 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 28687336 | ||
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 1.85e-07 | 3 | 199 | 3 | 8530044 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 21173785 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 24430292 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 20665013 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 27803446 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 1.85e-07 | 3 | 199 | 3 | 19954515 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | RSL1D1 PKD1L1 GHR CEP170 FGFR3 UNC13B RIPK3 ANK3 DSC2 ICE1 MACF1 SPEN PALLD | 1.91e-07 | 361 | 199 | 13 | 26167880 |
| Pubmed | SETX RSL1D1 CEP57L1 TIAM2 C5orf34 SGMS1 ANLN NFX1 SEC16A STK24 TICRR ANK3 TUT7 AKNAD1 HUWE1 GRAMD2A ZNF750 PPP2R5E SLC20A1 MACF1 NFAT5 TNS1 | 3.16e-07 | 1084 | 199 | 22 | 11544199 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 SETX MYO9A UBN1 UBR5 SEC16A ZDBF2 HUWE1 GSK3A FAM83B ARNT BRF1 ATF7IP MACF1 CRYBG3 SPEN | 3.28e-07 | 588 | 199 | 16 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RSL1D1 MED14 BPTF UBA1 UBN1 ANLN BRPF1 ZBTB21 MSL3 SEC16A MKI67 PLA2G4A UTP20 THOC1 HUWE1 GSK3A SCRIB SPEN | 5.85e-07 | 774 | 199 | 18 | 15302935 |
| Pubmed | Zscan5b Deficiency Impairs DNA Damage Response and Causes Chromosomal Aberrations during Mitosis. | 7.35e-07 | 4 | 199 | 3 | 31155506 | |
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 7.35e-07 | 4 | 199 | 3 | 7704034 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 28990182 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 19706858 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 2009263 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 21798861 | ||
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 7.35e-07 | 4 | 199 | 3 | 16025294 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 27732952 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 23755828 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ZSCAN5DP TSHZ2 MED14 NCKAP5 UBE4A BPTF TULP4 SYDE2 PAPPA2 ZSCAN5A ZSCAN5C TNS1 | 1.40e-06 | 363 | 199 | 12 | 14691545 |
| Pubmed | Regulation of the epithelial adhesion molecule CEACAM1 is important for palate formation. | 1.79e-06 | 16 | 199 | 4 | 23613893 | |
| Pubmed | 1.83e-06 | 5 | 199 | 3 | 19415824 | ||
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 1.83e-06 | 5 | 199 | 3 | 20857895 | |
| Pubmed | PSG3 PSG9 SVEP1 PTPN12 UBR5 BRD1 FHL2 PAPPA2 ANK3 HUWE1 ARNT PPP2R5E ATF7IP MACF1 INVS | 1.83e-06 | 591 | 199 | 15 | 15231748 | |
| Pubmed | 2.33e-06 | 17 | 199 | 4 | 7851895 | ||
| Pubmed | SETX RSL1D1 PTPN1 UBR5 SYDE2 SEC16A MKI67 CLEC16A ANK3 DSC2 BEND3 HUWE1 FAM83B FRMD6 ATF7IP SCRIB SPEN | 2.77e-06 | 777 | 199 | 17 | 35844135 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX ATAD5 RSL1D1 RPL10A DHX15 CEP170 BPTF UBN1 ANLN SEC16A MKI67 THOC1 BEND3 MSL1 ICE1 ZDBF2 FANCM ATF7IP SPEN | 2.78e-06 | 954 | 199 | 19 | 36373674 |
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 3.64e-06 | 6 | 199 | 3 | 17635176 | |
| Pubmed | MYO10 UBN1 BRPF1 SEC16A FGFR3 MSL1 HUWE1 MACF1 ZNF518B SCRIB ALPK2 | 3.79e-06 | 332 | 199 | 11 | 37433992 | |
| Pubmed | ZSCAN5DP ZC3H8 ZNF236 BPTF HOXB6 BRPF1 ZBTB21 ZNF286B DOP1B ZSCAN5A TUT7 ZNF750 ARNT ZSCAN20 ZSCAN5C NFAT5 ZNF292 | 4.64e-06 | 808 | 199 | 17 | 20412781 | |
| Pubmed | RSL1D1 NCBP1 RPL10A DHX15 CEP170 BPTF UBR5 SEC16A MKI67 UTP20 TUT7 BEND3 HUWE1 MACF1 SPEN | 6.11e-06 | 653 | 199 | 15 | 22586326 | |
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 6.35e-06 | 7 | 199 | 3 | 7794280 | |
| Pubmed | SETX RSL1D1 UBA1 PTPN12 ANLN SEC16A MKI67 PLA2G4A STK39 HUWE1 SCRIB SPEN PALLD | 7.48e-06 | 503 | 199 | 13 | 16964243 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RSL1D1 NCBP1 RPL10A DHX15 CEP170 BPTF UBA1 UBR5 ZBTB21 SEC16A MKI67 UTP20 THOC1 HUWE1 FAM83B SLC20A1 MACF1 SCRIB SPEN | 7.61e-06 | 1024 | 199 | 19 | 24711643 |
| Pubmed | 1.01e-05 | 24 | 199 | 4 | 34233187 | ||
| Pubmed | 1.01e-05 | 8 | 199 | 3 | 1690992 | ||
| Pubmed | 1.22e-05 | 52 | 199 | 5 | 23260145 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SDE2 SETX ATAD5 NCBP1 BPTF UBN1 ANLN BRPF1 ZBTB21 MKI67 BRD1 MSL1 SPEN ZNF292 | 1.22e-05 | 608 | 199 | 14 | 36089195 |
| Pubmed | Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. | 1.51e-05 | 9 | 199 | 3 | 22767893 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SETX ATAD5 RSL1D1 ZC3H8 ESCO1 RPL10A DHX15 BPTF UBN1 MSL3 MKI67 UTP20 FHL2 THOC1 TICRR ZSCAN5A BEND3 MSL1 FANCM ARNT SPEN | 1.87e-05 | 1294 | 199 | 21 | 30804502 |
| Pubmed | 1.91e-05 | 28 | 199 | 4 | 8672132 | ||
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 20602612 | ||
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 18652815 | ||
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 19651758 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO10 MED14 IRF5 ZNF236 TIAM2 UBN1 PER2 TULP4 NFX1 SEC16A UNC13B TPST2 ICE1 CFAP43 HUWE1 WDR59 IFNLR1 GRAMD2A SPEN | 2.19e-05 | 1105 | 199 | 19 | 35748872 |
| Pubmed | 2.27e-05 | 263 | 199 | 9 | 34702444 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 2.57e-05 | 205 | 199 | 8 | 12040188 | |
| Pubmed | CYP2C9 MYO10 ZNF236 RPL10A TRAPPC13 UBE4A UBA1 UBN1 UBR5 SEC16A BRD1 MSL1 ZDBF2 PREPL WDR59 ARNT PPP2R5E BRF1 CLEC14A SLC20A1 ZNF292 | 2.71e-05 | 1327 | 199 | 21 | 32694731 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | RSL1D1 MELK RPL10A MKI67 UTP20 THOC1 TICRR BEND3 HEATR6 SCRIB SPEN | 2.71e-05 | 410 | 199 | 11 | 26949251 |
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | CYP2C8 ESD ANKS1B FAM217A ANLN CCDC14 AKNAD1 HUWE1 CCDC74A TNS1 CRBN | 2.71e-05 | 410 | 199 | 11 | 25814554 |
| Pubmed | 2.78e-05 | 151 | 199 | 7 | 17043677 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 2.94e-05 | 11 | 199 | 3 | 15469410 | |
| Pubmed | 2.94e-05 | 11 | 199 | 3 | 15039299 | ||
| Pubmed | ESCO1 CEP170 UBE4A TULP4 ZNF286B TANGO6 FANCM WDR59 MACF1 N4BP1 ZNF518B PALLD | 3.03e-05 | 493 | 199 | 12 | 15368895 | |
| Pubmed | UBR5 ZBTB21 SEC16A TANGO6 BEND3 ICE1 ZDBF2 HUWE1 ATF7IP CRYBG3 PROX1 | 3.23e-05 | 418 | 199 | 11 | 34709266 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 21310852 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 7574697 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 2328001 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 30562214 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 26122864 | ||
| Pubmed | Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. | 3.26e-05 | 2 | 199 | 2 | 12435384 | |
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 3.26e-05 | 2 | 199 | 2 | 18511451 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 18694831 | ||
| Pubmed | Developmental expression of human hepatic CYP2C9 and CYP2C19. | 3.26e-05 | 2 | 199 | 2 | 14634042 | |
| Pubmed | CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. | 3.26e-05 | 2 | 199 | 2 | 10908295 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 1847130 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 28513222 | ||
| Pubmed | Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. | 3.26e-05 | 2 | 199 | 2 | 17599801 | |
| Pubmed | Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers. | 3.26e-05 | 2 | 199 | 2 | 30154342 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15385837 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 25518510 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 16372821 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15842554 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 19136640 | ||
| Pubmed | Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage. | 3.26e-05 | 2 | 199 | 2 | 35748067 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 20890775 | ||
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 3.26e-05 | 2 | 199 | 2 | 32587777 | |
| Pubmed | Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. | 3.26e-05 | 2 | 199 | 2 | 17201743 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 32683556 | ||
| Pubmed | Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers. | 3.26e-05 | 2 | 199 | 2 | 18548238 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15855721 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 19847408 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 17504998 | ||
| Pubmed | Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors. | 3.26e-05 | 2 | 199 | 2 | 24519941 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 14623888 | ||
| Pubmed | Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. | 3.26e-05 | 2 | 199 | 2 | 14646690 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 19480553 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 22589111 | ||
| Pubmed | CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. | 3.26e-05 | 2 | 199 | 2 | 15660966 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 18154472 | ||
| Pubmed | Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. | 3.26e-05 | 2 | 199 | 2 | 15766564 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.61e-07 | 11 | 132 | 4 | 1315 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 7.95e-04 | 57 | 132 | 4 | 1179 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX MYO10 MELK BICD1 DHX15 CEP170 PTPN1 BPTF PTPN12 SGMS1 UBR5 UTP20 STK39 CLEC16A STK24 DOP1B CHST3 PPP2R5E MACF1 N4BP1 CRYBG3 SPEN ZNF292 | 1.52e-07 | 856 | 198 | 23 | M4500 |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | MYO9A SCRN1 DOP1B TANGO6 ANK3 SIDT2 PPP2R5E LPIN2 CRBN PROX1 | 2.61e-06 | 196 | 198 | 10 | M9243 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 9.80e-06 | 180 | 198 | 9 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYO10 MELK DHX15 CEP170 BPTF PTPN12 UBR5 STK39 CLEC16A STK24 DOP1B PPP2R5E SPEN ZNF292 | 1.35e-05 | 466 | 198 | 14 | M13522 |
| Coexpression | GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP | 2.18e-05 | 199 | 198 | 9 | M5978 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 3.61e-05 | 265 | 198 | 10 | M1684 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 SETX MYO9A MYO10 ZC3H8 DPP8 CEP170 TRAPPC13 BPTF ANLN MKI67 TUT7 BLZF1 ATF7IP CEP57 PALLD | 4.20e-05 | 656 | 198 | 16 | M18979 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 4.50e-05 | 272 | 198 | 10 | MM1027 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CPNE2 BDP1 MYO9A ATAD5 MYO10 MED14 GON4L NCBP1 NCKAP5 PTPN1 C5orf34 UBR5 MKI67 FGFR3 TUT7 ZDBF2 HUWE1 PREPL CEP164 RSPO3 HEATR6 SLC20A1 ERCC6L2 CRBN ZNF292 | 1.56e-07 | 831 | 193 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | MYO9A ETFDH MED14 HMGCS2 ESCO1 CDAN1 PTPN12 SGMS1 PLA2G4A STK39 STK24 TDRD5 DSC2 DDX60 AFF3 TEX15 MSMP SCUBE1 SIDT2 FRMD6 ATF7IP NFAT5 ZNF292 | 9.18e-07 | 791 | 193 | 23 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | SDE2 TSHZ2 SCRN1 HMGCS2 SVEP1 TIAM2 GHR SGMS1 SYDE2 PLA2G4A STK24 TICRR DSC2 KIF26B AFF3 ZDBF2 COQ10B TEX15 SCUBE1 GUCY1A1 LPIN2 ZNF518B PALLD | 3.03e-06 | 849 | 193 | 23 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | TSHZ2 MYO9A ATAD5 MYO10 SCRN1 HMGCS2 SVEP1 GHR ANLN PLA2G4A PAPPA2 KIF26B AFF3 ZDBF2 SCUBE1 GUCY1A1 ATF7IP TNS1 PALLD PRLR | 2.45e-05 | 768 | 193 | 20 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | TSHZ2 MYO9A SCRN1 HMGCS2 SVEP1 GHR PLA2G4A PAPPA2 DSC2 AFF3 ZDBF2 SCUBE1 GUCY1A1 PALLD | 3.05e-05 | 418 | 193 | 14 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 MYO9A CEP57L1 GON4L UBE4A C5orf34 MKI67 FGFR3 CLEC16A TICRR TUT7 HUWE1 PREPL CEP164 HEATR6 ADAMTS6 ERCC6L2 MACF1 N4BP1 CRBN | 3.05e-05 | 780 | 193 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CPNE2 BDP1 ATAD5 MYO10 RSL1D1 MED14 SCRN1 NCBP1 NCKAP5 BICD1 PTPN1 UBR5 MKI67 UTP20 FGFR3 UNC13B ZDBF2 RSPO3 SCUBE1 SLC20A1 SLCO1A2 ZNF292 PROX1 | 3.50e-05 | 989 | 193 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | MED14 NCKAP5 BICD1 PTPN1 UBE4A STK39 BRD1 ZDBF2 SLC20A1 PROX1 | 4.21e-05 | 225 | 193 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CPNE2 BDP1 ATAD5 MYO10 RSL1D1 SCRN1 NCBP1 NCKAP5 BICD1 UBR5 FGFR3 ZDBF2 RSPO3 SLC20A1 PROX1 | 5.34e-05 | 498 | 193 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 ATAD5 CEP57L1 MED14 CEP170 UBE4A BPTF MKI67 BRD1 STK24 ICE1 FANCM SLC20A1 MACF1 N4BP1 ZNF292 | 6.11e-05 | 564 | 193 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | TSHZ2 MYO9A SCRN1 HMGCS2 SVEP1 GHR ANLN PLA2G4A STK39 PAPPA2 TICRR DSC2 KIF26B AFF3 ZDBF2 TEX15 SCUBE1 GUCY1A1 ZNF518B PALLD | 6.87e-05 | 827 | 193 | 20 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | CPNE2 ATAD5 MYO10 MED14 NCKAP5 BICD1 FGFR3 UNC13B ZDBF2 ZNF292 PROX1 | 9.37e-05 | 298 | 193 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | CPNE2 ATAD5 MYO10 MED14 SCRN1 NCKAP5 MELK PPM1H BICD1 KCNJ2 FGFR3 UNC13B PAPPA2 ZDBF2 FANCM BLZF1 FAM83B SCUBE1 LPIN2 MACF1 ZNF292 PROX1 | 9.59e-05 | 986 | 193 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.04e-04 | 203 | 193 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 1.08e-04 | 52 | 193 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | TSHZ2 MYO9A HMGCS2 PLA2G4A STK39 PAPPA2 DSC2 TEX15 SCUBE1 GUCY1A1 NFAT5 PALLD | 1.10e-04 | 357 | 193 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 SETX ATAD5 NCBP1 ESCO1 PTPN1 PTPN12 UBR5 ANLN HEATR5A ZDBF2 FANCM SLCO1A2 ZNF518B CEP57 | 1.11e-04 | 532 | 193 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CEP57L1 MED14 NCKAP5 BICD1 CEP170 PTPN1 UBE4A BPTF MKI67 BRD1 STK24 ZDBF2 SLC20A1 MACF1 N4BP1 ZNF292 | 1.14e-04 | 595 | 193 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 1.35e-04 | 210 | 193 | 9 | GSM403995_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | TSHZ2 MYO9A HMGCS2 SVEP1 GHR PLA2G4A STK39 PAPPA2 DSC2 AFF3 TEX15 SCUBE1 ARNT FRMD6 GUCY1A1 ATF7IP NFAT5 PALLD | 1.50e-04 | 740 | 193 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 ATAD5 UBE4A KCNJ2 MKI67 THOC1 TICRR KIF26B RSPO3 SLC20A1 MACF1 N4BP1 ZNF292 | 1.71e-04 | 432 | 193 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | MYO9A ETFDH HMGCS2 STK39 STK24 DSC2 FRMD6 ATF7IP NFAT5 ZNF292 | 1.79e-04 | 268 | 193 | 10 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | SDE2 TSHZ2 MYO9A ATAD5 SVEP1 GHR PLA2G4A STK39 PAPPA2 DSC2 KIF26B AFF3 ZDBF2 TEX15 SCUBE1 ADAMTS6 GUCY1A1 ATF7IP PALLD | 2.16e-04 | 831 | 193 | 19 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 2.18e-04 | 224 | 193 | 9 | GSM403994_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | MYLK TSHZ2 MYO9A ATAD5 NCKAP5 SVEP1 GHR ANLN PLA2G4A PAPPA2 KIF26B AFF3 ZDBF2 SCUBE1 ARNT GUCY1A1 PALLD PRLR | 2.55e-04 | 773 | 193 | 18 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.74e-04 | 231 | 193 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | SETX MYO10 PPM1H STK39 NLRC3 DDX60 AFF3 SCML4 CD2 ADAMTS6 MACF1 | 2.80e-04 | 338 | 193 | 11 | GSM403987_500 |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | SETX ATAD5 MED14 MKI67 NLRC3 TDRD5 TICRR DDX60 SCML4 CD2 ADAMTS6 | 2.87e-04 | 339 | 193 | 11 | GSM399382_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 3.39e-04 | 143 | 193 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | MYO9A MED14 HMGCS2 PLA2G4A STK24 TDRD5 DSC2 AFF3 TEX15 SCUBE1 FRMD6 NFAT5 | 3.42e-04 | 404 | 193 | 12 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TSHZ2 MYO10 CEP57L1 SCRN1 HMGCS2 SVEP1 GHR ANLN PLA2G4A DSC2 KIF26B AFF3 ZDBF2 SCUBE1 GUCY1A1 ZNF518B PALLD PRLR | 3.46e-04 | 793 | 193 | 18 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 3.83e-04 | 38 | 193 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.84e-04 | 192 | 193 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.85e-04 | 146 | 193 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | MYO9A PDK4 ETFDH HMGCS2 PLA2G4A STK39 STK24 DSC2 AFF3 TEX15 FRMD6 NFAT5 | 4.26e-04 | 414 | 193 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | MED14 SCRN1 HMGCS2 CAVIN4 SGMS1 SYDE2 PLA2G4A PLCB2 STK39 UNC13B DSC2 ZDBF2 MKNK1 SCUBE1 SIDT2 SLC20A1 LPIN2 N4BP1 SCRIB | 4.65e-04 | 884 | 193 | 19 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 SETX ATAD5 MYO10 RSL1D1 MED14 IRF5 BICD1 BPTF PTPN12 ANLN MKI67 UTP20 BRD1 THOC1 TICRR BEND3 ZDBF2 FANCM SLC20A1 MACF1 ZNF518B CEP57 ZNF292 | 4.70e-04 | 1257 | 193 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | SETX MYLK PDK4 GHR CEP170 ANLN DSC2 ABI3BP HUWE1 SPHKAP ERCC6L2 NFAT5 | 5.05e-04 | 422 | 193 | 12 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | TSHZ2 SVEP1 TIAM2 GHR KIF26B ZDBF2 SCUBE1 GUCY1A1 ZNF518B PALLD | 5.81e-04 | 311 | 193 | 10 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.17e-04 | 114 | 193 | 6 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | SCRN1 HMGCS2 GHR SYDE2 PLA2G4A DSC2 AFF3 ZDBF2 TEX15 SCUBE1 GUCY1A1 PALLD | 6.20e-04 | 432 | 193 | 12 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500 | MYO9A MED14 SCRN1 HMGCS2 SGMS1 PLA2G4A STK39 DSC2 AFF3 TEX15 SCUBE1 SIDT2 | 6.20e-04 | 432 | 193 | 12 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 6.31e-04 | 207 | 193 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100 | 6.43e-04 | 19 | 193 | 3 | gudmap_developingGonad_e18.5_ovary_100_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 6.43e-04 | 19 | 193 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CPNE2 MYO9A MYO10 MED14 SCRN1 HMGCS2 CAVIN4 PTPN12 SGMS1 PLA2G4A STK39 STK24 DSC2 AFF3 TEX15 SCUBE1 SIDT2 LPIN2 | 6.53e-04 | 837 | 193 | 18 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 ATAD5 CEP57L1 MED14 CEP170 UBE4A BPTF MKI67 BRD1 STK24 RSPO3 SLC20A1 MACF1 N4BP1 ZNF292 | 6.59e-04 | 629 | 193 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.85e-04 | 77 | 193 | 5 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 7.52e-04 | 20 | 193 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k2_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 SETX ATAD5 MYO10 RSL1D1 MED14 ANKS1B IRF5 BICD1 BPTF PTPN12 ANLN MKI67 UTP20 BRD1 THOC1 TICRR BEND3 ZDBF2 FANCM SCUBE1 SLC20A1 MACF1 ZNF518B CEP57 ZNF292 | 7.60e-04 | 1459 | 193 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | SETX MYO10 RSL1D1 MED14 HOXB6 TANGO6 THOC1 TICRR ANK3 KIF26B HUWE1 RSPO3 HEATR6 LPIN2 ERCC6L2 NFAT5 ZNF292 | 7.86e-04 | 779 | 193 | 17 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | TSHZ2 MYO9A HMGCS2 GHR PLA2G4A STK39 STK24 PAPPA2 DSC2 AFF3 TEX15 SCUBE1 FRMD6 GUCY1A1 ATF7IP NFAT5 PALLD | 8.31e-04 | 783 | 193 | 17 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | SDE2 MED14 SVEP1 TIAM2 GHR SGMS1 PLA2G4A STK24 TDRD5 DSC2 KIF26B AFF3 ZDBF2 TEX15 SCUBE1 FRMD6 GUCY1A1 PALLD | 8.67e-04 | 858 | 193 | 18 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_500 | 8.71e-04 | 21 | 193 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | MYO9A HMGCS2 PLA2G4A STK39 PAPPA2 DSC2 AFF3 TEX15 SCUBE1 GUCY1A1 PALLD | 8.83e-04 | 388 | 193 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO9A CEP57L1 UBR5 ANK3 ABI3BP ZDBF2 PREPL ATF7IP ERCC6L2 PALLD | 1.38e-08 | 188 | 199 | 10 | 6468fa95ad0395395301115286f2d8c0df5d3882 |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO9A CEP57L1 UBR5 ANK3 ABI3BP ZDBF2 PREPL ATF7IP ERCC6L2 PALLD | 1.38e-08 | 188 | 199 | 10 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO9A CEP57L1 UBR5 ANK3 ABI3BP ZDBF2 PREPL ATF7IP ERCC6L2 PALLD | 1.38e-08 | 188 | 199 | 10 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.36e-08 | 199 | 199 | 10 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-07 | 134 | 199 | 8 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.66e-07 | 186 | 199 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-07 | 187 | 199 | 9 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-07 | 187 | 199 | 9 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-07 | 189 | 199 | 9 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-07 | 190 | 199 | 9 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-07 | 190 | 199 | 9 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-07 | 191 | 199 | 9 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-07 | 191 | 199 | 9 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-07 | 191 | 199 | 9 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-07 | 191 | 199 | 9 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-07 | 192 | 199 | 9 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-07 | 192 | 199 | 9 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.48e-07 | 195 | 199 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 195 | 199 | 9 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-07 | 196 | 199 | 9 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-07 | 196 | 199 | 9 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.59e-07 | 196 | 199 | 9 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.70e-07 | 197 | 199 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 200 | 199 | 9 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.11e-07 | 151 | 199 | 8 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-06 | 170 | 199 | 8 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-06 | 174 | 199 | 8 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 175 | 199 | 8 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.98e-06 | 186 | 199 | 8 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.98e-06 | 186 | 199 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.15e-06 | 188 | 199 | 8 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-06 | 189 | 199 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.23e-06 | 189 | 199 | 8 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-06 | 190 | 199 | 8 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-06 | 190 | 199 | 8 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-06 | 190 | 199 | 8 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 191 | 199 | 8 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.41e-06 | 191 | 199 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 192 | 199 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.56e-06 | 135 | 199 | 7 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | E15.5-Mesenchymal|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.61e-06 | 193 | 199 | 8 | 22a9f5b61f197757f72840b9cb849cdb20430e72 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.61e-06 | 193 | 199 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.61e-06 | 193 | 199 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 194 | 199 | 8 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-06 | 194 | 199 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 194 | 199 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.71e-06 | 194 | 199 | 8 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 194 | 199 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 194 | 199 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 194 | 199 | 8 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 194 | 199 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-06 | 195 | 199 | 8 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-06 | 195 | 199 | 8 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 195 | 199 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 196 | 199 | 8 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.92e-06 | 196 | 199 | 8 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 196 | 199 | 8 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.04e-06 | 197 | 199 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.04e-06 | 197 | 199 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-06 | 198 | 199 | 8 | 11f21a4a97da10fc6ae604cb627aa3af749d9dff | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-06 | 198 | 199 | 8 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-06 | 198 | 199 | 8 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.27e-06 | 199 | 199 | 8 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | E16.5-Mesenchymal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-06 | 199 | 199 | 8 | ebd9ca151434f5ca27a82d4f1815a1ea500c1989 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-06 | 200 | 199 | 8 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-06 | 164 | 199 | 7 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-06 | 164 | 199 | 7 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-06 | 164 | 199 | 7 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-06 | 164 | 199 | 7 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-05 | 169 | 199 | 7 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 171 | 199 | 7 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 171 | 199 | 7 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 1.31e-05 | 173 | 199 | 7 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-05 | 175 | 199 | 7 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.41e-05 | 175 | 199 | 7 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 178 | 199 | 7 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 178 | 199 | 7 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.57e-05 | 178 | 199 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 179 | 199 | 7 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 179 | 199 | 7 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 179 | 199 | 7 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 179 | 199 | 7 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 180 | 199 | 7 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 181 | 199 | 7 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.75e-05 | 181 | 199 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 183 | 199 | 7 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.88e-05 | 183 | 199 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 184 | 199 | 7 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 184 | 199 | 7 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 184 | 199 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.94e-05 | 184 | 199 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 185 | 199 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.01e-05 | 185 | 199 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 2.01e-05 | 185 | 199 | 7 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 185 | 199 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 187 | 199 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| Computational | Neighborhood of CDKN1C | 4.60e-07 | 27 | 122 | 6 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 1.34e-06 | 32 | 122 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 2.34e-06 | 35 | 122 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 7.10e-06 | 42 | 122 | 6 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.22e-05 | 46 | 122 | 6 | GNF2_TIMP2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.77e-05 | 49 | 122 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of KISS1 | 1.77e-05 | 49 | 122 | 6 | GNF2_KISS1 | |
| Computational | Cytochrome P450. | 4.74e-04 | 14 | 122 | 3 | MODULE_106 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 3.78e-07 | 8 | 198 | 4 | ctd:C585955 | |
| Drug | sitaxsentan | 1.12e-06 | 10 | 198 | 4 | ctd:C106276 | |
| Drug | carveol | 2.60e-06 | 12 | 198 | 4 | CID000007438 | |
| Drug | bufuralol | 6.40e-06 | 5 | 198 | 3 | ctd:C010831 | |
| Drug | diosmetin | 1.21e-05 | 17 | 198 | 4 | ctd:C039602 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 1.27e-05 | 6 | 198 | 3 | ctd:C570106 | |
| Drug | 4',5-dihydroxydiclofenac | 1.27e-05 | 6 | 198 | 3 | CID003052567 | |
| Drug | AC1O5Z5L | 1.27e-05 | 6 | 198 | 3 | CID006443527 | |
| Drug | 3'-hydroxydiclofenac | 1.27e-05 | 6 | 198 | 3 | CID000112230 | |
| Drug | 16-O-demethylaconitine | 2.21e-05 | 7 | 198 | 3 | ctd:C486136 | |
| Drug | 5-fluorotryptamine | 2.21e-05 | 7 | 198 | 3 | ctd:C034536 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 2.21e-05 | 7 | 198 | 3 | CID005486899 | |
| Drug | nirvanol | 2.96e-05 | 21 | 198 | 4 | CID000091480 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 3.51e-05 | 8 | 198 | 3 | CID006439499 | |
| Drug | 11-HODE | 3.51e-05 | 8 | 198 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 3.51e-05 | 8 | 198 | 3 | ctd:C040997 | |
| Drug | testosterone enanthate | MYO9A RSL1D1 PDK4 HMGCS2 BPTF HOXB6 UBN1 ANK3 SLCO1A2 MACF1 SPEN NFAT5 CEP57 PALLD PRLR PROX1 | 4.61e-05 | 575 | 198 | 16 | ctd:C004648 |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.68e-05 | 191 | 198 | 9 | 3926_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.68e-05 | 191 | 198 | 9 | 4168_DN | |
| Drug | NO-1886 | 4.85e-05 | 46 | 198 | 5 | CID000131601 | |
| Drug | Tryptamines | 5.24e-05 | 9 | 198 | 3 | ctd:D014363 | |
| Drug | 5-chlorotryptamine | 5.24e-05 | 9 | 198 | 3 | ctd:C529169 | |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 5.24e-05 | 9 | 198 | 3 | ctd:C109602 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 5.24e-05 | 9 | 198 | 3 | ctd:C000588958 | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.28e-05 | 194 | 198 | 9 | 4309_DN | |
| Drug | Tolbutamide | 6.08e-05 | 25 | 198 | 4 | ctd:D014044 | |
| Drug | Ticlopidine | 6.08e-05 | 25 | 198 | 4 | ctd:D013988 | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; HL60; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 2985_UP | |
| Drug | norketobemidone | 7.43e-05 | 10 | 198 | 3 | CID000161154 | |
| Drug | dibenzylfluorescein | 7.52e-05 | 2 | 198 | 2 | ctd:C558664 | |
| Drug | Somatropin recombinant | 7.52e-05 | 2 | 198 | 2 | DB00052 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.37e-05 | 88 | 191 | 6 | EFO_0803332 | |
| Disease | X-21258 measurement | 1.25e-04 | 3 | 191 | 2 | EFO_0800802 | |
| Disease | disease progression measurement, response to xenobiotic stimulus | 1.25e-04 | 3 | 191 | 2 | EFO_0008336, GO_0009410 | |
| Disease | cD177 antigen measurement | 2.03e-04 | 18 | 191 | 3 | EFO_0021866 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 2.48e-04 | 4 | 191 | 2 | EFO_0801909 | |
| Disease | Congenital dyserythropoietic anemia | 4.12e-04 | 5 | 191 | 2 | C0002876 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 6.15e-04 | 6 | 191 | 2 | EFO_0801907 | |
| Disease | sclerosing cholangitis | 8.96e-04 | 66 | 191 | 4 | EFO_0004268 | |
| Disease | response to xenobiotic stimulus | 1.23e-03 | 182 | 191 | 6 | GO_0009410 | |
| Disease | transmembrane protein 9 measurement | 1.46e-03 | 9 | 191 | 2 | EFO_0803190 | |
| Disease | Liver carcinoma | 1.82e-03 | 507 | 191 | 10 | C2239176 | |
| Disease | X-11308 measurement | 2.21e-03 | 11 | 191 | 2 | EFO_0800693 | |
| Disease | thalamus volume | 2.29e-03 | 85 | 191 | 4 | EFO_0006935 | |
| Disease | response to anticoagulant | 2.37e-03 | 41 | 191 | 3 | GO_0061476 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 2.64e-03 | 12 | 191 | 2 | C0403553 | |
| Disease | thymol sulfate measurement | 2.64e-03 | 12 | 191 | 2 | EFO_0021170 | |
| Disease | age of onset of multiple sclerosis | 2.64e-03 | 12 | 191 | 2 | OBA_2001029 | |
| Disease | neuroimaging measurement, brain volume measurement | 2.71e-03 | 286 | 191 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | age at assessment, pelvic organ prolapse | 2.72e-03 | 43 | 191 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | blood urea nitrogen measurement | 2.86e-03 | 452 | 191 | 9 | EFO_0004741 | |
| Disease | plasma beta-amyloid 1-42 measurement | 3.10e-03 | 13 | 191 | 2 | EFO_0005660 | |
| Disease | Thrombus | 3.30e-03 | 46 | 191 | 3 | C0087086 | |
| Disease | serum metabolite measurement | CYP2C8 CYP2C9 PKD1L1 ETFDH TAAR3P NCKAP5 HMGCS2 PCDH15 PLA2G4A STK39 FHL2 KIF26B SLCO1A2 ZNF518B | 3.53e-03 | 945 | 191 | 14 | EFO_0005653 |
| Disease | body weight | ATAD5 ANKS1B GON4L BICD1 GHR BPTF TULP4 ANLN PCDH15 STK39 UNC13B PAPPA2 HUWE1 BCDIN3D WDR59 SPHKAP SCRIB | 3.55e-03 | 1261 | 191 | 17 | EFO_0004338 |
| Disease | apolipoprotein A 1 measurement | CPNE2 TSHZ2 TRAIP ETFDH DHX15 TANGO6 PAPPA2 MYO1H AFF3 CEP164 RSPO3 LPIN2 MACF1 | 3.67e-03 | 848 | 191 | 13 | EFO_0004614 |
| Disease | osteoarthritis, knee | 3.74e-03 | 158 | 191 | 5 | EFO_0004616 | |
| Disease | Thrombosis | 3.95e-03 | 49 | 191 | 3 | C0040053 | |
| Disease | response to antineoplastic agent | 3.97e-03 | 99 | 191 | 4 | GO_0097327 | |
| Disease | Endometrioma | 4.05e-03 | 161 | 191 | 5 | C0269102 | |
| Disease | Endometriosis | 4.05e-03 | 161 | 191 | 5 | C0014175 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 4.14e-03 | 15 | 191 | 2 | EFO_0800301 | |
| Disease | pulse pressure measurement | CYP2C9 ETFDH IRF5 SVEP1 DHX15 SGMS1 UGT2A1 BRD1 FHL2 CLEC16A PAPPA2 HEATR5A CEP164 RSPO3 GUCY1A1 NFAT5 PALLD HYDIN | 4.20e-03 | 1392 | 191 | 18 | EFO_0005763 |
| Disease | diastolic blood pressure, systolic blood pressure | MYO9A DHX15 SEC16A VWA3B FHL2 CLEC16A TANGO6 UNC13B ANK3 CEP164 NFAT5 | 4.46e-03 | 670 | 191 | 11 | EFO_0006335, EFO_0006336 |
| Disease | susceptibility to bacterial meningitis measurement | 4.67e-03 | 52 | 191 | 3 | EFO_0008411 | |
| Disease | IGF-1 measurement | 4.71e-03 | 488 | 191 | 9 | EFO_0004627 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 4.71e-03 | 16 | 191 | 2 | EFO_0800305 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.17e-03 | 243 | 191 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 5.32e-03 | 17 | 191 | 2 | EFO_0008270 | |
| Disease | C-reactive protein measurement | TRAIP ETFDH IRF5 CCDC168 BPTF SEC16A PCDH15 FAM227A ANK3 MAP3K8 BCDIN3D IFNLR1 RSPO3 SPHKAP MACF1 NFAT5 | 5.40e-03 | 1206 | 191 | 16 | EFO_0004458 |
| Disease | ecosanoids measurement | 5.47e-03 | 55 | 191 | 3 | EFO_0020044 | |
| Disease | forced expiratory volume | ATAD5 TRAIP SVEP1 HOXB6 TULP4 PCDH15 CLEC16A AFF3 SLCO1A2 ERCC6L2 NFAT5 TNS1 | 5.51e-03 | 789 | 191 | 12 | EFO_0004314 |
| Disease | Alzheimer disease, educational attainment | 5.58e-03 | 247 | 191 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | sexual dimorphism measurement | C3orf62 ATAD5 ETFDH RPL10A BPTF UBN1 SEC16A PAPPA2 RIPK3 TUT7 MSL1 CEP164 MSMP RSPO3 MACF1 | 5.75e-03 | 1106 | 191 | 15 | EFO_0021796 |
| Disease | Feeding difficulties | 5.96e-03 | 18 | 191 | 2 | C0232466 | |
| Disease | non-alcoholic steatohepatitis (is_marker_for) | 5.96e-03 | 18 | 191 | 2 | DOID:0080547 (is_marker_for) | |
| Disease | disease free survival | 5.96e-03 | 18 | 191 | 2 | EFO_0000409 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIEAKACVSSPPRNS | 381 | Q8NAT2 | |
| QEPLFKQIAKCVSSP | 341 | Q16537 | |
| PDVCQPSLREKEIKS | 511 | P51826 | |
| TCKEEQRPRTANKAP | 526 | P51826 | |
| YKPTTDEPTTVICQK | 336 | P04003 | |
| ECKIKSPESVPVDSN | 81 | Q96QE3 | |
| VPTCSALARKPDKLT | 116 | P27540 | |
| CREETFKQESQPPEK | 776 | Q5SW79 | |
| KTVRKELENNPPSCL | 36 | F5H4B4 | |
| PDNFIAACTEKKIPV | 236 | P10768 | |
| PFCKVPVITSSKEEQ | 136 | Q9H3F6 | |
| NKENSERPPVCLRTK | 76 | O95696 | |
| PPAKKRSLTLRDDCQ | 2381 | A6H8Y1 | |
| PCEVVAFSDRKLKPL | 76 | Q8NDM7 | |
| RDSVPLEFECINPKK | 256 | Q96FN4 | |
| SKEKRLTVAPPDCQQ | 911 | Q96G01 | |
| DCKKLNFSISPPTFV | 646 | Q68DQ2 | |
| KFLTCPKILESSVDP | 1391 | Q86TB3 | |
| PKEICARTFFKITAP | 56 | Q9H8M1 | |
| VKRAEKECPFPDALT | 116 | Q7Z5W3 | |
| DPKKRPCFLDITIET | 271 | Q8NFD2 | |
| KVSKESSVEPVSCPE | 191 | P06729 | |
| EDKATPCVPNARRIK | 246 | Q86XR8 | |
| SLNKCQIFPSKPVSR | 201 | Q96SW2 | |
| LRKTKASPCDPTFIL | 156 | P10632 | |
| VPQCFVRPTEAKKAA | 596 | O43143 | |
| PSSRPRVADLKKCFE | 786 | Q8IV53 | |
| VSIRSPETKCPKQNS | 1296 | Q12830 | |
| SLSKKCLSPPVAERA | 331 | Q96AQ1 | |
| QEKFRCPTSLSVVKD | 136 | Q5BKX8 | |
| KIPAATKEPEEQTAC | 866 | Q49A88 | |
| PVSEERSLSKPKTCF | 201 | Q8IWY9 | |
| NDNSPFIPKKTVIIC | 571 | Q02487 | |
| LSKTFPAAQCPEESK | 991 | Q9UKP5 | |
| LAFTKKCTIEEAPPT | 471 | Q8WWL7 | |
| SFKEPLALQESPTCK | 1026 | Q8WWL7 | |
| PNTPLCSARDLAEKK | 351 | P63252 | |
| TPSKARNQCLKETPI | 466 | Q14680 | |
| CIPSREPKNLAKEVA | 396 | Q16654 | |
| PERSSKDFCKIPLDE | 691 | Q5T5X7 | |
| AVTKKPCSLEIARAP | 461 | Q7Z6G8 | |
| REEKFSPATPSNCKL | 101 | Q8N635 | |
| EASDFPCRVAKLPKN | 26 | P18031 | |
| KLESCKDSPRTAPQT | 321 | Q15746 | |
| CLSQDPESPKPKFVR | 436 | Q09161 | |
| VSSFKLKEEGRPPCL | 91 | P40205 | |
| SNTVACTDPKKEIPV | 231 | Q7RTR2 | |
| KIPSTVEFCSTPAEK | 321 | Q9H2G9 | |
| KFSKPTCFLLEVPEA | 211 | Q8IU57 | |
| LPLKADFVCSTVQKP | 811 | Q9NQW6 | |
| RKKTSFREACAVPEP | 1031 | Q9Y3R5 | |
| KASPPTELVKATQRC | 61 | A1A4Y4 | |
| AVVCREKPKASPDNL | 1326 | Q2KJY2 | |
| PPFTTVDSQKDCRKF | 1761 | Q8IYD8 | |
| QPFPLRTTKVCFLEK | 426 | Q8IY21 | |
| RSPSQKKADFCIFPI | 196 | Q86V42 | |
| FKPTLPEQKEVNSCT | 546 | Q5T0W9 | |
| PKRLASRKCVSPEEF | 446 | P54868 | |
| CKLIPVDQFKPSDVE | 166 | P41279 | |
| ATLKRKCEFPANVPA | 601 | O15055 | |
| EKNEPLCVSVDSKFP | 786 | Q9Y5G4 | |
| RCSVLPSPKSQDKIS | 66 | A0A1B0GTH6 | |
| KVLCFEPDPTKARVL | 16 | Q8N5Y2 | |
| LKDPSPKTRACALQV | 466 | Q6AI08 | |
| SLCSVVPPDEKIFKE | 1446 | Q9HD67 | |
| IPKDDLNERPAKSTC | 281 | Q12986 | |
| TVSKEECEKVPFSPR | 566 | O94854 | |
| ECEKVPFSPRTAEFK | 571 | O94854 | |
| SCPNPIQREVKTKLF | 356 | Q13568 | |
| KELFQTPVCTDKPTT | 1471 | P46013 | |
| VCKRELRSQETPEKP | 376 | Q68DK7 | |
| TKLKKTPTEAPADCR | 6 | Q7Z6Z7 | |
| KKEISSPARPCSFEE | 556 | O94916 | |
| TNEFPSPCLDSKTKV | 31 | Q7Z6M3 | |
| NAKRKLSDDPCPVES | 611 | O60244 | |
| LSDDPCPVESKKTKR | 616 | O60244 | |
| PEPRKSDCAQDKSVF | 101 | P17509 | |
| QKKPRSTAEPEEICT | 491 | Q8WX93 | |
| DVRKTCFDPDSPKRA | 651 | Q9BXP8 | |
| STTTVCKTDPQREPK | 1866 | Q96QU1 | |
| QSTDSLPQTICRKPK | 521 | Q96NE9 | |
| LPQTICRKPKTSTDR | 526 | Q96NE9 | |
| SDFERLKPAKDCTPI | 491 | Q16134 | |
| VEKAKIENSPTPFCV | 321 | Q5T8I9 | |
| KPKEFTISPDCGTIR | 636 | Q4G0P3 | |
| IQLCPKTEFQPSEKF | 2091 | Q9Y2F5 | |
| CVFPASPKDLETEKS | 581 | Q86XA9 | |
| KVFKSRTPPEAIALC | 366 | P49840 | |
| LRKTKASPCDPTFIL | 156 | P33261 | |
| TKAVCTRKYNPIPSV | 176 | P13671 | |
| PKFTKCRSPERETFS | 51 | P10912 | |
| ALCPERKPLTSKENV | 106 | Q6ZUJ4 | |
| PSDFKCPIKEEIAIT | 501 | Q6V1X1 | |
| RKSTQPDVCASPQEK | 196 | Q3T8J9 | |
| SPSFLKPKRICSQRV | 721 | Q5T1N1 | |
| QEPCGRLSFLKEPKT | 1406 | Q12955 | |
| RCQQPIGTKSFIPKD | 131 | Q14192 | |
| DTTICSDRPPENEKK | 356 | Q6VMQ6 | |
| KPFNVTETRCLPKPS | 286 | Q8IYX8 | |
| KCPQKTTRRDETKPV | 226 | Q5FWF5 | |
| PVTVCPKFLVDSSTK | 941 | Q86VF2 | |
| QETEDSCPKSRKLAP | 76 | Q8NDH2 | |
| LRKTKASPCDPTFIL | 156 | P11712 | |
| ETLCEKAPLAAPFKR | 1511 | Q5T890 | |
| TCKPPEEQLTFKDLV | 581 | P22607 | |
| ATPKVRQPKLCDSLS | 326 | Q8IXS0 | |
| NSPVSCKEKPDRVEE | 26 | Q8IUY3 | |
| CPFLSETIIPSERKK | 81 | Q96MH7 | |
| PRENKDVLTFTCEPK | 251 | Q00888 | |
| QRKLVEPKHCFTSPD | 141 | Q6IQ49 | |
| CSDAPTTPIKQKARF | 476 | Q8IWY4 | |
| RKIEREIKCSPSESP | 256 | Q8WUM9 | |
| CAVLALKFPEAPTVK | 821 | O94829 | |
| LSETKELSCPEKPLF | 1826 | Q8TDX9 | |
| TLPGSVKKRVCFPSE | 141 | P0C7A2 | |
| CSEKRFLLPSQSSKP | 186 | Q9H8W4 | |
| PRENKDVLAFTCEPK | 251 | Q16557 | |
| DTEPKAKCAPQKRRT | 781 | Q9Y283 | |
| KEKVNTAQCPLPLFT | 316 | P47712 | |
| SPEKVSPVKICDFDL | 221 | Q9BUB5 | |
| DLKPPRIDSKDVFCA | 691 | Q5VT97 | |
| IPEDLSSCPKFVNKI | 6 | Q9P1P4 | |
| ECITKPVSFLPQNKE | 1756 | O75691 | |
| PRKDSVTECKQPPVS | 1371 | Q2M3C7 | |
| KVERTLCQPPTKNES | 111 | Q8NBJ9 | |
| SSVYPKERPEKLTSC | 526 | O14513 | |
| CLNKEPSFRPTAKEL | 266 | Q9Y6E0 | |
| PRENKDVLAFTCEPK | 251 | Q00887 | |
| KLDSEVPEIFKSPNC | 716 | Q92786 | |
| SASPCIADKISKPQE | 466 | Q05209 | |
| PKKFRQCPEPTSTAE | 1271 | Q7Z333 | |
| RPTQDPSECTKEVKS | 141 | P46721 | |
| KACKSQTPSERPTAQ | 311 | Q9H5K3 | |
| IPTPSRSESKYKIQC | 361 | Q8TC41 | |
| RNDIPEIPESIKFCK | 91 | Q14160 | |
| PRENKDVSTFTCEPK | 251 | Q13046 | |
| SNSLETKKASPFCRP | 976 | Q4LDE5 | |
| VRPKKVCFSESSLPT | 156 | Q9H0A9 | |
| VDDVKLVPKTQSPCF | 311 | Q12765 | |
| DVKTFCHNLRATKPP | 6 | P55201 | |
| NEKSEPKICRNLVTP | 316 | Q9UPV0 | |
| RSLCEDPVCTPFVKK | 226 | Q7LGC8 | |
| VKLCFHESPSSQPRK | 421 | Q86T13 | |
| SSAKPSIRCFIKPTE | 356 | Q2KHT3 | |
| EFVLPTSQRKCKSPE | 41 | P48736 | |
| VSEQDRVPKCPKSNS | 56 | Q32MQ0 | |
| RPVKKSTECLPAQAA | 456 | Q32MQ0 | |
| RLTATEKKVPQPCSS | 926 | Q9NRJ4 | |
| EKKVPQPCSSATLNR | 931 | Q9NRJ4 | |
| FSREPICPFEEKTKV | 11 | Q8N587 | |
| PPAEANKSSEDIRCK | 16 | Q9P0T7 | |
| PARVLCNKDPFTLKS | 151 | O60704 | |
| FPTCPNRKKVFVEDD | 126 | Q9ULJ3 | |
| VTPKKLFTSPLCDVS | 1306 | Q7Z2Z1 | |
| RCPKRSKPDATSISQ | 291 | P0CG00 | |
| VANEDAVKPSTLCPK | 606 | P17040 | |
| PPAERTKNVCKDVET | 81 | P17023 | |
| CERDATPAIKTQRPK | 26 | Q13156 | |
| FTLPCRKPKAFVEDT | 356 | Q8IVF5 | |
| QSPEKPRSCNKLSRE | 846 | Q96T58 | |
| QFSLVQKSDPRLPCK | 101 | Q1L6U9 | |
| KRPSARTQGPVKCES | 706 | O15027 | |
| KDRPSFQECLPKTDE | 271 | Q9Y572 | |
| PTRFFTEKKIPHECL | 226 | Q9ULR3 | |
| CLFTKDEPNSTPEKT | 96 | O76021 | |
| TRAFNVPPCKLASKD | 121 | Q9UBI4 | |
| CKLVIPNRDPTDESK | 1566 | Q9HBL0 | |
| PEIFKCRSPNKETFT | 31 | P16471 | |
| PFKCVVPTCTKTFTR | 1946 | O60281 | |
| SCPKESDPIQALRKL | 51 | Q9BUG6 | |
| IRQEEDPPKSKCSRL | 1961 | Q9HCK1 | |
| GFCPTKRKLLTPAEE | 231 | Q9C0B7 | |
| PPTNETRKCTVQRKK | 191 | Q9BXY4 | |
| QEDFKKPPLCRVSSD | 41 | Q86VZ5 | |
| PSRSFSCKDLQPVKQ | 66 | Q4J6C6 | |
| QSPPRASQVVKDCVK | 911 | O14795 | |
| EKSIPICTLKNFPNA | 626 | P22314 | |
| KKRVFDVNRPCSPDS | 321 | Q9NRE2 | |
| LRTCFPSEAKDKPER | 1146 | Q00722 | |
| KSTPRPKFSVCVLGD | 56 | P62906 | |
| PKKSCKRREPIQAST | 506 | Q92994 | |
| REKRAEVLKFVSCPP | 876 | Q6PJI9 | |
| CTEEKRNFAKPSPSA | 711 | Q9NPG3 | |
| EDPTCPVCNKKFSRV | 91 | Q9UL36 | |
| GPSLSSQKPRVFKCD | 1711 | Q9UL36 | |
| PAPAREEIKSTCSLK | 66 | P0CG31 | |
| DKETCLIPAVQEPKF | 486 | Q14139 | |
| ISTPEKCAKPQSDVD | 726 | Q502W6 | |
| KEPQVTFPIKEPSCS | 101 | Q64LD2 | |
| PDASVLSKPIFCFVK | 2506 | Q9BXT5 | |
| KPDNSPCSITDSVKR | 801 | Q7Z7G0 | |
| PCSITDSVKRFPKEE | 806 | Q7Z7G0 | |
| REVSTKEDKPIQCTP | 1401 | Q5VYS8 | |
| LCLQKDPSKRPTAAE | 316 | Q9UEW8 | |
| KPTLFTNIPVTCEEK | 21 | A5PLN9 | |
| KSKFEVLVSDPVFPC | 141 | P0DTE4 | |
| SCPKESDPIQALRKL | 51 | A6NGD5 | |
| PFPRGCSASEKVQEK | 206 | Q8N228 | |
| CPSFVKERTSDTKPT | 396 | Q96FV9 | |
| FQRTPKKLCIPEKTE | 731 | O95071 | |
| QKQPKRPRSESSCSK | 396 | Q9BWF2 | |
| NKIQAEPSRCLKDPS | 901 | Q9C0D4 | |
| CEQIPKKFRHSAISP | 46 | Q8N5P1 | |
| KPCSEKVTDRPTSVN | 561 | A8MPX8 | |
| KFESCSVPRKINVSP | 606 | Q02108 | |
| PQTACPKSDSELEVK | 236 | Q92539 | |
| ISKEPSYIRCIKPND | 586 | Q8N1T3 | |
| PFKVEAKPCTSNCRI | 446 | O75113 | |
| SPELPGSCRKEFKEN | 1811 | B2RTY4 |